Insilico Medicine Receives Second Consecutive Prix Galien USA Best Start-Up Nomination
Insilico Medicine has been nominated for the 2026 Prix Galien USA “Best Start-Up” Award in the Biotechnology category, marking the second consecutive year that the clinical-stage biotechnology company has received recognition...
Read moreDetails





















